AstraZeneca Trial Participant Adverse Events Likely Unrelated To COVID-19 Vaccine: Oxford
Moderna Faces Hurdle With Coronavirus Vaccine As Court Refuses To Invalidate Arbutus Patent
AstraZeneca Strikes Deal With Four EU Countries Over 400M Coronavirus Vaccine Doses
Oxford University Coronavirus Vaccine Clinical Trial To Start Thursday With $24.6M Government Funding